Advertisement

Topics

Boehringer to develop fibrosis treatment with Inventiva

08:19 EDT 5 Sep 2017 | pharmaphorum

Boehringer Ingelheim has taken an option to develop treatments for idiopathic pulmonary fibrosis and fibrotic conditions with French biotech Inventiva. The German pharma company has been collaborating with Inventiva on R&D since May 2016 and a...

Original Article: Boehringer to develop fibrosis treatment with Inventiva

NEXT ARTICLE

More From BioPortfolio on "Boehringer to develop fibrosis treatment with Inventiva"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...